Zepp Health Corporation each representing sixteen (Class A) (ZEPP) carries a Roarable Rating of E (Strong Sell) with 25/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-02, Zepp Health Corporation each representing sixteen (Class A) (NYSE: ZEPP) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 25/100 at a spot price of $2.20 (-2.22% 1D, market cap $33.0M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 714 tracked Technology issuers, ZEPP ranks #670 in composite RQD confidence.
Within the Technology sector (Computer Manufacturing), ZEPP carries a Roarable E (25/100 RQD), trailing P/E of N/A, gross margin of 38.3%, and ROIC of -14.7%. By comparison, OSS (One Stop Systems Inc.) holds a D- grade (42/100 RQD, P/E 28.6x, ROIC -18.0%, cap $145.7M) and SCKT (Socket Mobile Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $3.0M). Among the 5-stock peer group, OSS leads on earnings multiple (28.6x) while OMCL leads on capital efficiency (0.4% ROIC).
Per ZEPP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001720446), Zepp Health Corporation each representing sixteen (Class A) generated $258.9M in revenue (+41.8% YoY), -$40.1M in net income, and -$26.2M in free cash flow against $564.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 0.33 (DISTRESS RISK (<1.8)) • Piotroski F-Score 5/9
FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 14.8 (OVERSOLD (<32))
Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)
While ZEPP currently carries a cautious 25/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Technology with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.90) and Max Pain ($2.31) forces dealer call-delta covering toward $44.47.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Zepp Health Corporation each representing sixteen (Class A) (ZEPP) dropped -2.22% to $2.20, trading at 2% of its 52-week range ($2.15 – $42.35). Stretched risk/reward at current multiples (-15% return on capital) under elevated 10-year interest-rate pressure.
MILPITAS, Calif., September 22, 2026--Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced the T-Rex Dual Solar, a premium expedition smartwatch built for long-distance and multi-day explo
Yahoo Finance coverage on ZEPP stock catalysts, institutional flow, and earnings outlook.
Zepp Health (NYSE:ZEPP) reported second-quarter 2026 revenue of $63.5 million, up 6.9% from a year earlier, as new product launches and a higher-priced product mix supported growth. Gross margin improved to 37.4% from 36
Yahoo Finance coverage on ZEPP stock catalysts, institutional flow, and earnings outlook.
Yahoo Finance coverage on ZEPP stock catalysts, institutional flow, and earnings outlook.
MILPITAS, Calif., June 25, 2026--Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced its support of iOS Notification Forwarding, a new Beta feature that provides eligible iPhone users in
MILPITAS, Calif., June 18, 2026--Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes b
Yahoo Finance coverage on ZEPP stock catalysts, institutional flow, and earnings outlook.
Zepp Health (NYSE:ZEPP) reported a stronger start to 2026, with management pointing to new Amazfit product launches, a higher-end product mix and expanding positioning in hybrid training as the main drivers of first-quar
Yahoo Finance coverage on ZEPP stock catalysts, institutional flow, and earnings outlook.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +41.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ZEPP today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ZEPP. Explore sector supply chains on /butterfly.
Across 714 tracked Technology securities in the Roarable RQD universe, Zepp Health Corporation each representing sixteen (Class A) (ZEPP) ranks #670 by composite RQD confidence (25/100, grade E) and #584 by equity capitalization ($33.0M). Within this direct 5-issuer industry benchmark cohort, OSS leads on earnings valuation at 28.6x trailing P/E, while OMCL leads on capital efficiency and profitability with 0.4% ROIC and 42.5% gross margin. OMCL currently holds the highest overall quantitative score in the immediate peer group at 53/100 (D+) compared with ZEPP at 25/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ZEPP
ACTIVE
Zepp Health Corporation each representing sixteen (Class A) | E | 25/100 | — | 38.3% | -14.7% | -2.22% | $33.0M | Benchmark Subject |
| OSS One Stop Systems Inc. | D- | 42/100 | 28.6x | 49.6% | -18.0% | -11.68% | $145.7M | /oss-vs-zepp → |
| SCKT Socket Mobile Inc. | D- | 36/100 | — | 49.7% | -35.0% | -7.82% | $3.0M | /sckt-vs-zepp → |
| XNDU Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares | D | 44/100 | — | — | — | -7.07% | $946.1M | /xndu-vs-zepp → |
| OMCL Omnicell Inc. ($0.001 par value) | D+ | 53/100 | — | 42.5% | 0.4% | -0.62% | $1.68B | /omcl-vs-zepp → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Zepp Health Corporation each representing sixteen (Class A) (ZEPP) reported GAAP revenue of $258.9M (+41.8% vs. FY2024 revenue of $182.6M , and -26.6% cumulative change since FY2023) , GAAP net income of -$40.1M, operating cash flow of -$25.7M, and free cash flow of -$26.2M (-1.6% YoY). On the balance sheet, ZEPP closed FY2025 with $564.8M in total assets against $0 in total debt (Altman Z-Score: 0.33, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $258.9M | -$40.1M | -$25.7M | -$26.2M | $564.8M | — |
| FY2024 (FY) | 2024-12-31 | $182.6M | -$75.7M | -$24.4M | -$25.8M | $528.6M | — |
| FY2023 (FY) | 2023-12-31 | $352.9M | -$31.0M | $42.6M | $42.6M | — | — |
As of 2026-11-02, Zepp Health Corporation each representing sixteen (Class A) (NYSE: ZEPP) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 25/100 at a spot price of $2.20 (-2.22% 1D, market cap $33.0M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 714 tracked Technology issuers, ZEPP ranks #670 in composite RQD confidence.
Within the Technology sector (Computer Manufacturing), ZEPP carries a Roarable E (25/100 RQD), trailing P/E of N/A, gross margin of 38.3%, and ROIC of -14.7%. By comparison, OSS (One Stop Systems Inc.) holds a D- grade (42/100 RQD, P/E 28.6x, ROIC -18.0%, cap $145.7M) and SCKT (Socket Mobile Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $3.0M). Among the 5-stock peer group, OSS leads on earnings multiple (28.6x) while OMCL leads on capital efficiency (0.4% ROIC).
Per ZEPP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001720446), Zepp Health Corporation each representing sixteen (Class A) generated $258.9M in revenue (+41.8% YoY), -$40.1M in net income, and -$26.2M in free cash flow against $564.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
ZEPP last traded at $2.20 (-2.22% on volume of 112,614 shares), positioning the stock -43.59% below its 50-day simple moving average ($3.90) and -78.15% below its 200-day simple moving average ($10.07). Across its 52-week range of $2.15 to $42.35, ZEPP sits at the 0.1% percentile with a 14-day RSI of 14.8 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.92 to $2.48).
Why ZEPP Stock dropped -2.22% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-15% return on capital) under elevated 10-year interest-rate pressure.
Per the Roarable RQD rating, ZEPP carries an RQD Score of 25 and a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." Across its five pillars:
For a prospective investor evaluating the stock today, the rating points to elevated forensic and operating risk rather than a value or growth setup. The most important tradeoff is that the stock trades at a $2.25 price with a $33.0M market cap, but the source data lacks earnings-based valuation multiples, so the price cannot be benchmarked against earnings. Upside would depend on a reversal in operating losses and cash generation, neither of which the source data shows as currently underway.
Zepp Health Corporation each representing sixteen (Class A) is a NYSE-listed issuer classified in the Technology sector and Computer Manufacturing industry, per the company profile. The profile does not describe its products, customers, or revenue model. Not available in source data for any further business detail.
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $258.9M | $-29.2M | $-40.1M | N/A | $-26.2M | $57.0M | N/A |
| FY 2024 | $182.6M | $-47.2M | $-75.7M | N/A | $-25.8M | $91.1M | N/A |
| FY 2023 | $352.9M | $-30.4M | $-31.0M | N/A | $42.6M | N/A | N/A |
Per the SEC financials, revenue moved from $352.9M in FY 2023 to $182.6M in FY 2024 before recovering to $258.9M in FY 2025, while operating and net losses persisted in every reported period. Per the market data, the gross margin is 38.3%, operating margin -11.3%, and net margin -15.5%, with ROIC at -14.7%. Per the Roarable RQD rating, the Altman Z-Score is 0.33 and the Piotroski F-Score is 5/9. Per the RQD forensic inputs, Debt/Equity is 0.5. Cash declined from $91.1M in FY 2024 to $57.0M in FY 2025, and FCF was negative in the two most recent periods.
Real-time company headlines, analyst actions, and sector developments for Zepp Health Corporation each representing sixteen (Class A) (ZEPP) • Click "Debate This Headline" to argue it in the Roar Pit below
MILPITAS, Calif., September 22, 2026--Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced the T-Rex Dual Solar, a premium expedition smartwatch built for long-distance and multi-day explo
Yahoo Finance coverage on ZEPP stock catalysts, institutional flow, and earnings outlook.
Zepp Health (NYSE:ZEPP) reported second-quarter 2026 revenue of $63.5 million, up 6.9% from a year earlier, as new product launches and a higher-priced product mix supported growth. Gross margin improved to 37.4% from 36
Yahoo Finance coverage on ZEPP stock catalysts, institutional flow, and earnings outlook.
Yahoo Finance coverage on ZEPP stock catalysts, institutional flow, and earnings outlook.
MILPITAS, Calif., June 25, 2026--Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced its support of iOS Notification Forwarding, a new Beta feature that provides eligible iPhone users in
MILPITAS, Calif., June 18, 2026--Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes b
Yahoo Finance coverage on ZEPP stock catalysts, institutional flow, and earnings outlook.
Welcome to the ZEPP (Zepp Health Corporation each representing sixteen (Class A)) Roar Pit. Current RQD Composite is 25/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Computer Manufacturing. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Everyone in here is repeating the bull case on ZEPP, but look at what you are paying: current EV/EBITDA multiples with 38.3% gross margins. Unless Zepp Health Corporation each representing sixteen (Class A) expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
Looking at the 5-pillar RQD breakdown on ZEPP, the market is fixating on short-term headline noise in Computer Manufacturing and ignoring the balance sheet and cash flow trajectory. At $2.25 (52-wk range $2.15 - $42.35), any beat on forward guidance forces shorts and underweight funds to chase.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).